Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Porschen

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische OnkologieS Lorenzen, T Schuster, R Porschen, et al.
British Journal of Cancer|April 12, 2007
Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAXO Nehls, T Okech, C-J Hsieh, et al.
Gut|December 13, 2002
Time gated fluorescence spectroscopy in Barrett's oesophagusM-A E J Ortner, B Ebert, E Hein, et al.
Zeitschrift Fur Gastroenterologie|February 24, 2001
[Diagnosis and therapy of ulcerative colitis--results of an evidence-based consensus conference of the German Society of Digestive and Metabolic Diseases]E F Stange, J Riemann, A von Herbay, et al.
Deutsche Medizinische Wochenschrift (1946)|April 23, 2005
[S3-guideline conference "Colorectal Cancer" 2004]W Schmiegel, C Pox, G Adler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2016
Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study groupD P Modest, I Ricard, V Heinemann, et al.
Zeitschrift Fur Gastroenterologie|March 10, 2009
[Gastrointestinal oncology - therapy update 2008 / 2009]M P Ebert, C Auernhammer, K Caca, et al.
Zeitschrift Fur Gastroenterologie|October 28, 2004
[S3-Guidelines Conference "Colorectal Carcinoma" 2004]W Schmiegel, C Pox, G Adler, et al.
Zeitschrift Fur Gastroenterologie|November 13, 2015
[Not Available]R Porschen, A Buck, W Fischbach, et al.
Zeitschrift Fur Gastroenterologie|January 15, 2010
S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII)W Schmiegel, C Pox, A Reinacher-Schick, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische OnkologieS Lorenzen, T Schuster, R Porschen, et al.
British Journal of Cancer|April 12, 2007
Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAXO Nehls, T Okech, C-J Hsieh, et al.
Gut|December 13, 2002
Time gated fluorescence spectroscopy in Barrett's oesophagusM-A E J Ortner, B Ebert, E Hein, et al.
Zeitschrift Fur Gastroenterologie|February 24, 2001
[Diagnosis and therapy of ulcerative colitis--results of an evidence-based consensus conference of the German Society of Digestive and Metabolic Diseases]E F Stange, J Riemann, A von Herbay, et al.
Deutsche Medizinische Wochenschrift (1946)|April 23, 2005
[S3-guideline conference "Colorectal Cancer" 2004]W Schmiegel, C Pox, G Adler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2016
Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study groupD P Modest, I Ricard, V Heinemann, et al.
Zeitschrift Fur Gastroenterologie|March 10, 2009
[Gastrointestinal oncology - therapy update 2008 / 2009]M P Ebert, C Auernhammer, K Caca, et al.
Zeitschrift Fur Gastroenterologie|October 28, 2004
[S3-Guidelines Conference "Colorectal Carcinoma" 2004]W Schmiegel, C Pox, G Adler, et al.
Zeitschrift Fur Gastroenterologie|November 13, 2015
[Not Available]R Porschen, A Buck, W Fischbach, et al.
Zeitschrift Fur Gastroenterologie|January 15, 2010
S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII)W Schmiegel, C Pox, A Reinacher-Schick, et al.
Pageof 12